Dymon Asia Capital (Singapore)’s Thermo Fisher Scientific TMO Stock Holding History

Dymon Asia Capital (Singapore)’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.01M	Hold	8,000	–	–	0.17%	84
2026 Q1	$3.93M	Buy	+8,000	New	+$4.34M	0.4%	72
2025 Q1	–	Sell	-2,400	Closed	-$1.25M	–	179
2024 Q4	$1.25M	Sell	2,400 -100	-4%	-$55K	0.29%	66
2024 Q3	$1.55M	Sell	2,500 -500	-17%	-$296K	0.42%	53
2024 Q2	$1.66M	Buy	3,000 +1,300	+76%	+$745K	0.44%	58
2024 Q1	$988K	Sell	1,700 -800	-32%	-$449K	0.22%	75
2023 Q4	$1.33M	Buy	+2,500	New	+$1.21M	0.39%	61
2021 Q1	–	Sell	-712	Closed	-$332K	–	180
2020 Q4	$332K	Buy	+712	New	+$334K	0.07%	96

Other funds holding TMO

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Dymon Asia Capital (Singapore)'s TMO Position: Q2 2026 in Review

Dymon Asia Capital (Singapore) held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 8,000 shares worth $4.01M. The position accounts for 0.17% of the portfolio, ranked #84.

Dymon Asia Capital (Singapore) first reported a position in TMO in Q4 2020 and has held it in 8 quarters since. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Dymon Asia Capital (Singapore) held 8,000 shares of Thermo Fisher Scientific worth $4.01M as of Q2 2026.
Dymon Asia Capital (Singapore) left its Thermo Fisher Scientific share count unchanged in Q2 2026.
Thermo Fisher Scientific made up 0.17% of Dymon Asia Capital (Singapore)'s portfolio in Q2 2026, its #84 holding.
Dymon Asia Capital (Singapore) first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 8 quarters since.
1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q2 2026, filed 23 Jul 2026.